Global Cell Expansion Market Report and Forecast 2024-2032

Global Cell Expansion Market Outlook

The global cell expansion market size was valued at USD 21 billion in 2023, driven by the rising incidence of chronic diseases and intensive research activities for cell-based therapies. The market is expected to grow at a CAGR of 16.2% during the forecast period of 2024-2032, with the values likely to reach USD 81 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell Expansion Market Overview
 

The cell expansion market is experiencing significant growth and innovation, particularly in the fields of cell therapy, regenerative medicine, and biotechnology. Billions of therapeutic cells are usually needed for a single dose of cell therapy. Thus, cell culture and expansion form a critical step in the manufacturing as well as development of cell therapy, which has the potential to address the unmet medical needs of a growing population base. With cell-based therapies currently undergoing rapid development to treat chronic diseases such as cancer, diabetes, and neurodegenerative diseases, the cell expansion market demand is expected is witness a striking surge.

Key drivers of the market include the rise in geriatric population and the growing prevalence of chronic diseases. In the United States, heart disease is the most common cause of mortality followed by cancer. Further, it is estimated that 41 out of 100 men and 39 out of 100 women will develop cancer in their lifetime. The increased risk of developing cancer prompts the need for effective therapeutics, which is expected to accelerate the market growth of the cell expansion sector. In addition, intensive research activities directed at developing novel cell therapies will boost the market size. These research initiatives are increasingly supported by significant investments from private and public organizations, which will positively impact the market landscape.

The cell expansion market growth is also aided by the rising application of cell expansion protocols in regenerative medicine and stem cell research to counter the growing cancer cases. Technological advancements such as the automation of cell expansion processes will further augment the market share in the forecast period.

Intensive Research in Stem Cell Expansion

Robust research efforts in the field of cell expansion to support high manufacturing capacities have paved the way for rapid advancements. In May 2023, researchers from the University of Tokyo discovered a technique to scale up the number of human blood stem cells in the lab. The research, originally published in Nature, found that artificially boosting the PI3K phosphorylation mechanism can trigger the human blood stem cells or hematopoietic stem cells (HSCs) to expand successfully. The production of a large number of HSCs opens up new possibilities for medical therapies for treating leukemia and other blood disorders as well as for researchers studying blood stem function. This expanded scope of applications drives the need for cell expansion technologies, which may increase the cell expansion market share in the coming years.

Automation of Cell Expansion Protocols to Boost Market Value

Advances in cell expansion techniques and technologies including automation of cell expansion protocols are facilitating efficiency and scalability in cell manufacturing processes. These advancements will reduce production costs while improving the quality and consistency of cell-based products. Such developments are expected to expand the cell expansion market size in the coming years.

In January 2024, Multiply Labs (a United States-based robotics company that serves the pharmaceutical industry), in collaboration with Thermo Fisher Scientific, and Charles River, announced performance results for its proof-of-concept robotic system that aims at automating cell therapy manufacturing processes including cell quantity and quality. The data indicates that the new robotic technology can automate an existing cell expansion process without causing any significant protocol changes or affecting the quality of the final product. The integration of robotics not only minimizes bioprocess and regulatory risks but also speeds up the production of life-saving therapies.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell Expansion Market Segmentation

Market Breakup by Product

• Consumables
  • Media
  • Reagent
  • SERA
  • Disposables

• Instruments 
  • Cell Expansion Supporting Equipment
  • Bioreactors
  • Automated Cell Expansion Systems

Market Breakup by Cell Type

• Human Cell

• Animal Cell

Market Breakup by Application

• Regenerative Medicine and Stem Cell Research

• Cancer Research

• Drug Screening and Development

• Tissue Engineering

• Other Applications

Market Breakup by End User

• Biotechnology and Biopharmaceutical Companies

• Research Institutes

• Cell Banks

• Other End User

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Cell Expansion Market Regional Analysis

In North America, the cell expansion sector is flourishing due to the rising investments by biotechnology companies to develop effective therapies including cell-based therapies. Another key driver is the increased strategic partnerships among the key market players to speed up the development of their products. In November 2023, a United States-based company 908 Devices Inc. known for its chemical and biochemical analysis products, and Terumo Blood and Cell Technologies (Terumo BCT) announced a collaboration initiative to provide on-line monitoring of Terumo BCT products. This collaboration integrates 908 Devices' MAVEN, an on-line glucose and lactate analyzer, into Terumo BCT's Quantum Flex platform. This advancement aims to accelerate cell and gene therapy development and manufacturing by providing real-time insights and control without manual sampling.

Europe also holds a substantial cell expansion market share, owing to the growing geriatric population and the prevalence of various diseases. Moreover, the dominance of the regional market can be attributed to the presence of leading market players and a well-established healthcare system that is actively supporting technological advancements in the segment.

Global Cell Expansion Market: Competitor Landscape 

In February 2024, AstraZeneca, a global biopharmaceutical company, invested USD 300 million in its Maryland Facility to amplify cell therapy research. The investment will boost the cell therapy capabilities of AstraZeneca, with an initial impetus to critical cancer trials and future commercial supply. With a focus on developing T-cell therapies, the company is expected to create over 150 new jobs in the region. This investment will expand its footprint in cell therapy and novel treatments for various medical conditions. Such investment initiatives spur innovation and development in cell expansion technologies and support market growth.

The key features of the cell expansion market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific, Inc.

• GE Healthcare

• Corning Incorporated

• Miltenyi Biotec

• Merck KGaA

• Becton, Dickinson and Company

• TERUMO BCT, INC.

• Takara Bio Inc.

• Getinge AB

• Eppendorf AG

• Promocell GmbH

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report